the Afrikaner population.6 Four haplotypes defined by the restriction enzymes PvuII (P), Stul (S), and NcoI (N) were found to segregate in this population. In 71% of FH families studied, the defective gene cosegregated with the rare allele of a NcoI RFLP7 (P1S1N2 haplotype), while the rare allele of a StuI RFLP8 (P2S2N1 haplotype) segregated with FH in 20% of these families. We now report on haplotype associations of 10 different DNA polymorphisms at the LDL receptor gene locus in the normocholesterolaemic and FH populations and in a large number of FH homozygotes.
The prevalence of familial hypercholesterolaemia (FH), an autosomal dominant disease characterised by raised low density lipoprotein (LDL) cholesterol levels, is five to 10 times higher in the Afrikaner population than has been reported for most other population groups in the world.1 2 Seftel et al 1 have suggested a 'founder gene effect' to explain this abnormally high frequency. Clinical studies have indicated that tendon xanthomas and premature coronary artery disease (CAD) are encountered in middle aged FH heterozygotes, while in the homozygous condition both cutaneous and tendon xanthomas as well as aortic and coronary atherosclerosis generally appear before the age of 10 years. 3 Over recent years it has been shown by Brown and Goldstein4 that FH is caused by mutations in the LDL receptor gene. The availability of cDNA and genomic clones of this gene have now made it possible to characterise mutations at the DNA level.4 5 We have previously provided evidence for the existence of at least two 'founder' FH genes in the Afrikaner population.6 Four haplotypes defined by the restriction enzymes PvuII (P), Stul (S), and NcoI (N) were found to segregate in this population. In 71% of FH families studied, the defective gene cosegregated with the rare allele of a NcoI RFLP7 (P1S1N2 haplotype), while the rare allele of a StuI RFLP8 (P2S2N1 haplotype) segregated with FH in 20% of these families. We now report on haplotype associations of 10 different DNA polymorphisms at the LDL receptor gene locus in the normocholesterolaemic and FH populations and in a large number of FH homozygotes.
Subjects and methods
The FH heterozygous patients and normocholesterolaemic subjects were those previously described. Founder effects also play a role and probably underly the distinguishing RFLP frequencies in our Afrikaner population. A founder effect is well documented in this group which has remained isolated through religious belief and cultural bonds.
Pedigree analyses in normal and FH families have shown the presence of a small number of haplotypes in normal chromosomes. Only two of these haplotypes are associated with FH in the homozygous FH patients and we thus conclude that the defective LDL receptor genes associated with these haplotypes (2 and 6) account for the founder effect in the Afrikaner and probably represent two separate gene defects. Only four of the FH families studied (11%) have shown association with other haplotypes (1, 3, 4, and 13), which probably correspond to the 10 times lower FH frequency found in other population groups.
The nature of the alteration in the DNA structure of the LDL receptor genes underlying FH in the Afrikaner population has not yet been reported. Our results clearly indicate that haplotypes function as specific markers for FH in affected families. Early detection of carriers is thus possible, allowing for dietary and life style modification to reduce the subsequent risk of early heart disease.
